Compare DexCom, Inc. (DXCM) vs Southwest Airlines Co (LUV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Southwest Airlines Co — how do they compare? DexCom, Inc. trades at $90.08 (market cap $33.79B), while Southwest Airlines Co trades at $44.87 (market cap $22.27B). The key difference: DexCom, Inc. is the larger of the two by market cap, and Southwest Airlines Co pays a 1.58% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | LUV | |
|---|---|---|
Market Cap | $33.79B | $22.27B |
Sector | Health | Industrials |
52-Week High | $89.53 | $54.80 |
52-Week Low | $54.84 | $29.67 |
Enterprise Value | $33.24B | $25.37B |
Dividend Yield | — | 1.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $90.23, up 2.94% today and near its 52-week high, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating EPS estimates with $0.70 versus $0.61 expected, and raised full-year guidance. Revenue growth remains robust at 13% year-over-year, supported by G7 system adoption and international expansion. Profit margins improved, with net income margin reaching 20.12% in 2025. Analyst sentiment is overwhelmingly positive, with 80% buy ratings.
The outlook for DXCM is favorable due to sustained demand for continuous glucose monitors and strategic initiatives like 'Road to 100'. Key risks include competitive pressures, regulatory scrutiny, and valuation multiples above industry averages. The stock's current price is slightly above the consensus target of $88.65, suggesting near-term consolidation may occur before further upside.
Southwest Airlines (LUV) trades at $44.91, showing minimal daily movement. The stock exhibits a bearish technical trend, with key support at $45 and resistance at $46. Fundamentally, revenue grew to $28.06B in 2025, though net income margin compressed to 1.57%. Recent Q2 2026 earnings beat expectations with EPS of $0.94 versus $0.51 expected, while Q1 2026 missed. The company maintains a dividend of $0.18 per share and is focusing on business travel expansion.
LUV presents a mixed outlook. Analyst consensus is a Buy with a $53.86 price target, implying ~20% upside, supported by earnings rebound and strategic initiatives. However, risks include fuel cost volatility, competitive pressures, and bearish technical indicators. Investors should weigh solid liquidity and growth initiatives against margin pressures and macroeconomic sensitivities.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Southwest Airlines Co
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →
